Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D6SZ
|
||||
Former ID |
DIB004613
|
||||
Drug Name |
TROXACITABINE
|
||||
Synonyms |
Troxatyl; BCH-4556; SPD-758; Troxacitabine < Prop INN; Beta-L-OddC; (-)-beta-L-Dioxolanecytidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 2 | [521659] | ||
Company |
Shire Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C8H11N3O4
|
||||
Canonical SMILES |
NC1=NC(=O)N(C=C1)[C@@H]2CO[C@H](CO)O2
|
||||
InChI |
1S/C8H11N3O4/c9-5-1-2-11(8(13)10-5)6-4-14-7(3-12)15-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7-/m0/s1
|
||||
InChIKey |
RXRGZNYSEHTMHC-BQBZGAKWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Human DNA | Target Info | Binder | [527096] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.